X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Cancer Reports

期刊標題檢索 最新評論: 沒有評論


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Cancer Reports]您好,您是該頁面的第 10323 位訪客。

期刊簡介
期刊名稱Cancer Reports Cancer Reports

(According to the latest JCR data, this journal is not indexed in the JCR.)
LetPub Score
8.2
50 ratings
Rate

Reputation
8.0

Influence
8.3

Speed
7.8

期刊簡稱
ISSN2573-8348
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
2.700.5710.587
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q3255 / 404
Category: Medicine
Subcategory: Cancer Research
Q4177 / 230

自引率 (2023-2024)6.70%自引率趨勢
掲載範囲
Cancer Reports is an international, peer-reviewed, open access journal publishing basic, translational, clinical and interdisciplinary research in cancer biology, diagnosis, treatment, outcome, supportive care, epidemiology and health disparities. The journal considers data-driven, scientifically valid findings including incremental findings, pilot studies, replication and negative findings. Cancer Reports is a Wiley Open Access journal, one of a new series of peer reviewed titles publishing quality research with speed and efficiency.

Article types: Original Research, Brief Report, Method Report, Clinical Study Report, Registered Report, Case Report and Review (literature and systematic). Click here for more details. Cancer Reports publishes papers submitted directly to the journal and those referred from a select group of prestigious journals published by Wiley.

Cancer Reports just received a Journal Citation Indicator of 0.3, first Journal Impact Factor™ of 1.7 and CiteScore of 2.3.


Cancer Reports是一份国际性的、同行评审的开放获取期刊,致力于发表癌症生物学、诊断、治疗、疗效、支持治疗、流行病学和健康差异方面的基础、转化、临床和跨学科研究成果。本刊接收数据驱动的科学研究成果,包括渐进式研究结果、探索性研究成果、复制研究和反证成果。Cancer Reports是Wiley开放获取期刊,是一系列经过同行评审的新期刊之一,能够快速高效地发表高质量的研究成果。


文章类型:原创研究、简报、方法报告、临床研究报告、注册报告、病例报告和综述(文献综述和系统综述)。点击此处了解更多详情。Cancer Reports刊登直接向本刊投稿的论文以及从Wiley部分顶级期刊引用的论文。


Cancer Reports 最新期刊引文指标为0.3,期刊影响因子首次突破1.7,CiteScore为2.3。
官方網站https://onlinelibrary.wiley.com/journal/25738348
在線稿件提交https://mc.manuscriptcentral.com/cancerreports
開放訪問Yes
出版商Wiley
主題領域Medicine
出版國/地區United States
發行頻率月刊
創刊年2018
每年文章數173每年文章數趨勢
黃金OA百分比72.99%
OA Related Info
APC: Yes( USD2970; GBP2310; EUR2700; )
APC waiver:Check Notes
Other charges: No
Keywords: cancer biology、clinical oncology、bioinformatics、psycho-oncology、cancer immunology、anticancer agents
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q4

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYESCIQ4259/322
索引 (SCI or SCIE)
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2573-8348%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 17 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Cancer Reports】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature CancerH-index: 0

    CiteScore: 31.10
    JAMA OncologyH-index: 41

    CiteScore: 37.50
    JAMA OncologyH-index: 61

    CiteScore: 37.50
    Trends in CancerH-index: 0

    CiteScore: 28.50
    Liver CancerH-index: 25

    CiteScore: 20.80
    Experimental Hematology & OncologyH-index: 0

    CiteScore: 12.60
    ESMO OpenH-index: 0

    CiteScore: 11.70
    Cancer Biology & MedicineH-index: 29

    CiteScore: 9.80
    Annual Review of Cancer BiologyH-index: 0

    CiteScore: 14.50
    CancersH-index: 53

    CiteScore: 8.00
    學科內最受檢索的期刊 頁面查看次數
    Cancers209096
    OncoTargets and Therapy180488
    Cancer Management and Research149000
    Journal of Oncology88131
    Cancer Biology & Medicine58455
    Molecular Therapy-Oncolytics43558
    JAMA Oncology36938
    Liver Cancer34099
    Nature Cancer33298
    Translational Lung Cancer Research29386
  •  

    Cancer Reports Cancer Reports
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    下一頁    末頁  (0/0)
  [Cancer Reports] 的評論撰寫評論
暫無評論。
首頁    上一頁    下一頁    末頁  (0/0)

開始撰寫 [Cancer Reports] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*